Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
33,072.00
42,871.00
34,343.00
51,082.00
30,085.00
24,781.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
33,072.00
42,871.00
34,343.00
51,082.00
30,085.00
24,781.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
155.00
86.00
44.00
45.00
42.00
22.00
General and Administration Expenses
12,958.00
12,485.00
11,678.00
13,511.00
8,643.00
7,638.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
39,913.00
35,339.00
29,366.00
31,147.00
21,815.00
21,536.00
Operating Profit (PBDIT) excl Other Income
-6,841.00
7,532.00
4,977.00
19,935.00
8,270.00
3,245.00
Other Income
-482.00
-201.00
480.00
622.00
278.00
68.00
Operating Profit (PBDIT)
-3,949.00
10,528.00
7,454.00
22,502.00
10,440.00
4,747.00
Interest
155.00
86.00
44.00
45.00
42.00
22.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
3,374.00
3,197.00
1,997.00
1,945.00
1,892.00
1,434.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
-6,414.00
7,244.00
5,412.00
19,404.00
8,653.00
3,422.00
Provision for Tax
-1,718.00
1,707.00
1,625.00
4,886.00
1,764.00
742.00
Profit After Tax
-4,758.00
5,508.00
3,773.00
14,507.00
6,892.00
2,678.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
-38.43
43.92
30.22
116.79
55.52
21.59
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is -22.86% vs 24.83% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -190.83% vs 51.34% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 80.23% vs 95.45% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -186.38% vs 45.98% in Mar 2024
Compare Profit and Loss Results of JCR Pharmaceuticals Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
33,072.00
1,89,024.00
-1,55,952.00
-82.50%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
33,072.00
1,89,024.00
-1,55,952.00
-82.50%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
155.00
1,039.00
-884.00
-85.08%
General and Administration Expenses
12,958.00
23,518.00
-10,560.00
-44.90%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
39,913.00
1,68,784.00
-1,28,871.00
-76.35%
Operating Profit (PBDIT) excl Other Income
-6,841.00
20,240.00
-27,081.00
-133.80%
Other Income
-482.00
718.00
-1,200.00
-167.13%
Operating Profit (PBDIT)
-3,949.00
36,199.00
-40,148.00
-110.91%
Interest
155.00
1,039.00
-884.00
-85.08%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
3,374.00
15,241.00
-11,867.00
-77.86%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
-6,414.00
19,919.00
-26,333.00
-132.20%
Provision for Tax
-1,718.00
6,777.00
-8,495.00
-125.35%
Profit After Tax
-4,758.00
13,142.00
-17,900.00
-136.20%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
-38.4331
184.4481
-222.88
-120.84%
Profit And Loss - Net Sales
Net Sales 33,072.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -22.86% vs 24.83% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -6,841.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -190.83% vs 51.34% in Mar 2024
Profit And Loss - Interest
Interest 155.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is 80.23% vs 95.45% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax -4,758.00 Million
in Mar 2025Figures in Million
YoY Growth in year ended Mar 2025 is -186.38% vs 45.98% in Mar 2024






